CLINICAL_TRIALS ClinicalTrials.gov record update

A Feasibility Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06066138
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:08.101027+00:00
Published At: 2026-04-20T00:00:00+00:00
Record Updated At: 2026-04-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Locally Advanced Alveolar Soft Part Sarcoma", "Metastatic Alveolar Soft Part Sarcoma", "Locally Advanced Non Small Cell Lung Cancer", "Metastatic Non Small Cell Lung Cancer", "Locally Advanced Small Cell Lung Cancer", "Metastatic Small Cell Lung Cancer", "Locally Advanced Hepatocellular Carcinoma", "Metastatic Hepatocellular Carcinoma", "Locally Advanced Melanoma", "Metastatic Melanoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-04-20"
protocolSection.identificationModule.nctId: "NCT06066138"
protocolSection.identificationModule.officialTitle: "A Feasibility Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.